Performed stem cell transplantation according to the donor availability group in each cytogenetic subgroup and each age group
. | No donor, N = 441 . | . | Donor, N = 293 . | . | ||
|---|---|---|---|---|---|---|
. | Autologous (%) . | Allogeneic (%) . | Autologous (%) . | Allogeneic (%) . | ||
| Cytogenetics | ||||||
| Unknown | 92 (54.1) | 1 (0.6) | 2 (1.7) | 73 (61.9) | ||
| Successful | 154 (56.8) | 10 (3.7) | 5 (2.9) | 129 (73.7) | ||
| Good risk | 46 (63.0) | 1 (1.4) | 4 (8.0) | 36 (72.0) | ||
| Intermediate risk | 65 (62.5) | 2 (1.9) | 1 (1.6) | 46 (75.4) | ||
| Bad risk | 29 (51.8) | 2 (3.6) | 0 (0.0) | 17 (77.3) | ||
| Very bad risk | 14 (36.8) | 5 (13.2) | 0 (0.0) | 30 (71.4) | ||
| Age, y | ||||||
| Between 15 and 25 | 62 (54.4) | 4 (3.5) | 0 (0.0) | 45 (67.2) | ||
| Between 26 and 35 | 85 (59.9) | 2 (1.4) | 1 (1.1) | 67 (76.1) | ||
| Between 36 and 45 | 99 (53.5) | 5 (2.7) | 6 (4.3) | 90 (65.2) | ||
| Total | 246 (55.8) | 11 (2.5) | 7 (2.4) | 202 (68.9) | ||
. | No donor, N = 441 . | . | Donor, N = 293 . | . | ||
|---|---|---|---|---|---|---|
. | Autologous (%) . | Allogeneic (%) . | Autologous (%) . | Allogeneic (%) . | ||
| Cytogenetics | ||||||
| Unknown | 92 (54.1) | 1 (0.6) | 2 (1.7) | 73 (61.9) | ||
| Successful | 154 (56.8) | 10 (3.7) | 5 (2.9) | 129 (73.7) | ||
| Good risk | 46 (63.0) | 1 (1.4) | 4 (8.0) | 36 (72.0) | ||
| Intermediate risk | 65 (62.5) | 2 (1.9) | 1 (1.6) | 46 (75.4) | ||
| Bad risk | 29 (51.8) | 2 (3.6) | 0 (0.0) | 17 (77.3) | ||
| Very bad risk | 14 (36.8) | 5 (13.2) | 0 (0.0) | 30 (71.4) | ||
| Age, y | ||||||
| Between 15 and 25 | 62 (54.4) | 4 (3.5) | 0 (0.0) | 45 (67.2) | ||
| Between 26 and 35 | 85 (59.9) | 2 (1.4) | 1 (1.1) | 67 (76.1) | ||
| Between 36 and 45 | 99 (53.5) | 5 (2.7) | 6 (4.3) | 90 (65.2) | ||
| Total | 246 (55.8) | 11 (2.5) | 7 (2.4) | 202 (68.9) | ||
The exact number of patients in each cytogenetic or age group is given in Table 1.